lonafarnib has been researched along with Aging in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral, WA; Collins, FS; Cubria, MB; DuBose, A; Erdos, MR; Kamalapathy, P; Karim, L; Masoudi, A; Nazarian, A; Oftadeh, R; Snyder, BD; Suarez, S | 1 |
| Macicior, J; Marcos-Ramiro, B; Ortega-Gutiérrez, S | 1 |
| Jiang, K | 1 |
| Ghosh, S; Raghunath, M; Sinha, JK | 1 |
| Bancke Laverde, BL; Beirao Junior, PS; Carvalho, VO; Celli, A; Cunico, C; Lucas de Mello, M; Santos Piedade, G | 1 |
2 review(s) available for lonafarnib and Aging
| Article | Year |
|---|---|
Small-Molecule Therapeutic Perspectives for the Treatment of Progeria.
Topics: Aging; Aging, Premature; Cell Nucleus; Cellular Senescence; Fibroblasts; Humans; Lamin Type A; Laminopathies; Mutation; Nuclear Lamina; Phenotype; Piperidines; Progeria; Pyridines; Skin; Small Molecule Libraries | 2021 |
Progeria: a rare genetic premature ageing disorder.
Topics: Aging; Child; Clinical Trials as Topic; Humans; Lamin Type A; Longevity; Mutation; Piperidines; Prenylation; Progeria; Pyridines; Rare Diseases | 2014 |
3 other study(ies) available for lonafarnib and Aging
| Article | Year |
|---|---|
Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups.
Topics: Aging; Animals; Bone and Bones; Bone Density Conservation Agents; Cartilage; Disease Models, Animal; Femur; Glycosaminoglycans; Joints; Lamin Type A; Mice; Mice, Transgenic; Mutation; Osteoarthritis; Phenotype; Piperidines; Pravastatin; Progeria; Protein Processing, Post-Translational; Pyridines; X-Ray Microtomography; Zoledronic Acid | 2020 |
Drug development for progeria yields insights into normal aging.
Topics: Aging; Child; Clinical Trials as Topic; Diphosphonates; Drug Discovery; Humans; Imidazoles; Lamin Type A; Mutation; Piperidines; Pravastatin; Progeria; Pyridines; Time Factors; Zoledronic Acid | 2013 |
Progeria and the early aging in children: a case report.
Topics: Aging; Body Height; Body Weight; Child; Child, Preschool; Enzyme Inhibitors; Female; Humans; Infant; Lamin Type A; Piperidines; Progeria; Pyridines | 2016 |